Chlorpheniramine/dihydrocodeine/phenylephrine

InformationABT 702 dihydrochloride ABT-702 is a novel, potent non-nucleoside Adenosine kinase inhibitor with an IC50 of 1.7 nM. It has oral activity in animal models of pain and inflammation.Targetsadenosine kinase 1.7 nM.

InformationABT 702 dihydrochloride ABT-702 is a novel, potent non-nucleoside Adenosine kinase inhibitor with an IC50 of 1.7 nM. It has oral activity in animal models of pain and inflammation.Targetsadenosine kinase 1.7 nM.

InformationABT 702 dihydrochloride ABT-702 is a novel, potent non-nucleoside Adenosine kinase inhibitor with an IC50 of 1.7 nM. It has oral activity in animal models of pain and inflammation.Targetsadenosine kinase 1.7 nM.

InformationABT 702 dihydrochloride ABT-702 is a novel, potent non-nucleoside Adenosine kinase inhibitor with an IC50 of 1.7 nM. It has oral activity in animal models of pain and inflammation.Targetsadenosine kinase 1.7 nM.

Anti-CLDN7 claudin 7, 100ul UN 1687 6.1 PG2

Anti-CLDND2 claudin domain containing 2, 25ul UN 1687 6.1 PG

Anti-PLEKHA1 pleckstrin homology domain containing, family A

Anti-PLEKHA1 pleckstrin homology domain containing, family A

Anti-PLEKHA2 pleckstrin homology domain containing, family A

Anti-PLEKHA3 pleckstrin homology domain containing, family A

Anti-PLEKHA3 pleckstrin homology domain containing, family A

Anti-PLEKHA3 pleckstrin homology domain containing, family A